Dopamine receptor elevation by cholecystokinin-Reference-Cited by-同舟云学术

Dopamine receptor elevation by cholecystokinin

Published:1984-11 Issue:6 Volume:5 Page:1207-1212
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Dumbrille-Ross A.,Seeman Philip

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference25 articles.

1. Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites;Agnati;Acta Physiol Scand,1983

2. Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment;Chiodo;Nature,1980

3. Effects of intracerebroventricular administration of cholecystokinin-octapeptide-sulfate-ester on dopamine, norepinephrine and serotonin contents of different brain structures in rats;Fekete;Neuroendo Lett,1980

4. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites;Fuxe;Acta Physiol Scand,1981

5. Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection;Fuxe;Eur J Pharmacol,1980

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling methamphetamine use disorder and relapse in animals: Short- and long-term epigenetic, transcriptional., and biochemical consequences in the rat brain;Neuroscience & Biobehavioral Reviews;2023-12

2. Does endogenous cholecystokinin modulate alcohol intake?;Neuropharmacology;2021-08

3. Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis;Current Neuropharmacology;2021-06-23

4. The unappreciated roles of the cholecystokinin receptor CCK(1) in brain functioning;Reviews in the Neurosciences;2017-07-26

5. Cholecystokinin and Psychiatric Disorders;CNS Drugs;1997-08